AGMB (AGMB) Stock Price & Analysis
AGMB (AGMB) rose 6.41% to USD 15.78 as of September 8, 2026 at 09:39 UTC, according to Nexqual real-time market data.
AGMB last closed at USD 15.78; the session ranged USD 14.53–15.86 on volume of 245,268 shares. Market capitalization is —, with a 52-week range of USD 8.75–17.82 (NMS). Source: Nexqual, September 8, 2026 at 09:39 UTC.
Key Statistics (as of September 8, 2026 at 09:39 UTC)
| Price | USD 15.78 |
|---|---|
| Change | ▲ 6.41% (up) |
| Previous Close | USD 15.78 |
| Open | USD 15.78 |
| Day Range | USD 14.53 – 15.86 |
| 52-Week Range | USD 8.75 – 17.82 |
| Volume | 245,268 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (AGMB)
Nexqual's technical model rates AGMB "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 09:39 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 68.34 (neutral) |
| vs SMA50 | Above (USD 13.37) |
| MACD | 0.34 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EIKN | Eikon Therapeutics, Inc. | USD 10.86 | ▼ 4.57% |
| SPTX | Seaport Therapeutics, Inc. | USD 24.86 | ▼ 0.2% |
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| ODTX | Odyssey Therapeutics, Inc. | USD 28.76 | ▲ 8.04% |
| AVLN | Avalyn Pharma Inc. | USD 37.39 | ▲ 5.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:39 UTC. This page is informational and not investment advice.